Clinical Evaluation of Ranitidine and Omeprazole in Shortening Hospital Stay for Dyspepsia Patients

Riana Hartanti; Andres Manalo; Muhammad Zikri

doi:10.70716/mohr.v3i1.139

Authors

Riana Hartanti Universitas Pembangunan Nasional Veteran Jakarta, Jakarta, Indonesia
Andres Manalo University of Santo Tomas, Manila, Philippines
Muhammad Zikri Universitas Pembangunan Nasional Veteran Jakarta, Jakarta, Indonesia

DOI:

https://doi.org/10.70716/mohr.v3i1.139

Keywords:

dyspepsia, ranitidine, omeprazole, treatment duration, clinical effectiveness

Abstract

Dyspepsia is a common complaint of the upper gastrointestinal tract that often leads to a decrease in quality of life and increased healthcare burden. Two drugs commonly used in the treatment of dyspepsia are ranitidine, an H2 receptor antagonist, and omeprazole, a proton pump inhibitor. This study aims to evaluate the clinical effectiveness of ranitidine and omeprazole in reducing the length of treatment for dyspepsia patients. The study uses a quantitative method with a retrospective approach to the medical record data of inpatient dyspepsia patients at a hospital in Indonesia. The sample consisted of two groups of patients, each receiving ranitidine and omeprazole therapy. Analysis was performed on treatment duration, symptom improvement, and adverse events. The results showed that patients receiving omeprazole had a more significant reduction in average treatment duration compared to the ranitidine group. Furthermore, omeprazole had better tolerability with fewer side effects. These findings indicate that omeprazole is more clinically effective in accelerating the recovery of dyspepsia patients compared to ranitidine. This study provides a scientific basis for medical practitioners in choosing optimal therapy for dyspepsia, especially in the context of healthcare efficiency. Further research with a prospective design is needed to strengthen these findings.

Downloads

Download data is not yet available.

References

Azab, M., Doo, L., Doo, D. H., Elmofti, Y., Ahmed, M., Cadavona, J. J., ... & Yoo, J. W. (2017). Comparison of the hospital-acquired Clostridium difficile infection risk of using proton pump inhibitors versus histamine-2 receptor antagonists for prophylaxis and treatment of stress ulcers: a systematic review and meta-analysis. Gut and liver, 11(6), 781.

Camilleri, M., & Stanghellini, V. (2013). Current management strategies and emerging treatments for functional dyspepsia. Nature Reviews Gastroenterology & Hepatology, 10(3), 187-194.

De Sanctis, V., Soliman, A. T., Daar, S., Tzoulis, P., Fiscina, B., & Kattamis, C. (2022). Retrospective observational studies: Lights and shadows for medical writers. Acta Bio Medica: Atenei Parmensis, 93(5), e2022319.

Dehghani, S. M., Imanieh, M. H., Oboodi, R., & Haghighat, M. (2011). The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia. International Scholarly Research Notices, 2011(1), 219287.

Fasseas, P., Leybishkis, B., & Rocca, G. (2001). Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy. International journal of clinical practice, 55(10), 661-664.

Hanindiya, B. (2020). STUDY OF DRUG THERAPY IN PATIENTS WITH GASTRITIS IN PEMATANG RAYA HEALTH CENTER, SIMALUNGUN REGENCY, APRIL-JUNE 2017 PERIOD. MEDALION JOURNAL: Medical Research, Nursing, Health and Midwife Participation, 1(2), 78-89.

Hantoro, I. F., Syam, A. F., Mudjaddid, E., Setiati, S., & Abdullah, M. (2018). Factors associated with health-related quality of life in patients with functional dyspepsia. Health and quality of life outcomes, 16, 1-6.

Lin, X., Chen, H., & Lin, Y. N. (2021). The clinical efficacy and safety of atropine combined with omeprazole in the treatment of patients with acute gastritis: a systematic review and meta-analysis. Annals of palliative medicine, 10(9), 9535543-9539543.

Mahadeva, S., Yadav, H., Everett, S. M., & Goh, K. L. (2012). Economic impact of dyspepsia in rural and urban malaysia: a population-based study. Journal of neurogastroenterology and motility, 18(1), 43.

Nurhaliza, I., Prasuma, G. S., Sugiantoro, E. A., Lianawati, L., Sutheeraprasert, P., & Setiawan, D. (2023). Cost Effectiveness Analysis in Scientific Herbal Therapy Compared to Conventional Therapy for Dyspepsia. JURNAL ILMU KEFARMASIAN INDONESIA, 21(2), 201-208.

Saadah, A., Sarnianto, P., Utami R., H. ., & Irmin. (2022). Cost Utility Analysis of BPJS and Non-BPJS Dyspepsia Patients Combination of Ranitidine Antacids with Lansoprazole Antacids. Jurnal Kesehatan Komunitas (Journal of Community Health), 8(2), 352–361. https://doi.org/10.25311/keskom.Vol8.Iss2.1234

Simadibrata, M., Abdullah, M., Syam, A. F., Fauzi, A., Makmun, D., Manan, C., ... & Rahajeng, E. (2010). Dyspeptic Syndrome in Urban Population of Jakarta. Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 11(2), 66-70.

Spiegel, B. M., Vakil, N. B., & Ofman, J. J. (2002). Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology, 122(5), 1270-1285.

Yeomans, N. D., Tulassay, Z., Juhász, L., Rácz, I., Howard, J. M., van Rensburg, C. J., ... & Hawkey, C. J. (1998). A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. New England Journal of Medicine, 338(11), 719-726.